Healthcare provider profile · identity verified

Benjamin Leon

Internal Medicine · FORT COLLINS, CO · NPI 1609300441

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	474	145
Levothyroxine Sodium	Levothyroxine Sodium	451	122
Losartan Potassium	Losartan Potassium	345	100
Amlodipine Besylate	Amlodipine Besylate	275	74
Omeprazole	Omeprazole	254	87
Trazodone Hcl	Trazodone Hcl	211	61
Rosuvastatin Calcium	Rosuvastatin Calcium	203	65
Gabapentin	Gabapentin	200	64
Metformin Hcl	Metformin Hcl	127	40
Lisinopril	Lisinopril	126	35
Tamsulosin Hcl	Tamsulosin Hcl	109	39
Hydrochlorothiazide	Hydrochlorothiazide	103	31
Duloxetine Hcl	Duloxetine Hcl	102	35
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	98	33
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	94	45
Escitalopram Oxalate	Escitalopram Oxalate	93	30
Pantoprazole Sodium	Pantoprazole Sodium	85	31
Montelukast Sodium	Montelukast Sodium	81	29
Simvastatin	Simvastatin	80	22
Metoprolol Succinate	Metoprolol Succinate	78	23
Famotidine	Famotidine	76	30
Sertraline Hcl	Sertraline Hcl	75	21
Allopurinol	Allopurinol	74	24
Eliquis	Apixaban	73	22
Bupropion Xl	Bupropion Hcl	72	24
Synthroid	Levothyroxine Sodium	68	18
Furosemide	Furosemide	63	21
Potassium Chloride	Potassium Chloride	63	23
Prednisone	Prednisone	63	33
Mounjaro	Tirzepatide	62	11
Zolpidem Tartrate	Zolpidem Tartrate	62	24
Ozempic	Semaglutide	53	suppressed
Buspirone Hcl	Buspirone Hcl	50	19
Fluoxetine Hcl	Fluoxetine Hcl	49	14
Tramadol Hcl	Tramadol Hcl	46	22
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	45	40
Ezetimibe	Ezetimibe	45	14
Oxycodone Hcl	Oxycodone Hcl	44	15
Albuterol Sulfate Hfa	Albuterol Sulfate	42	24
Carvedilol	Carvedilol	42	13
Citalopram Hbr	Citalopram Hydrobromide	41	11
Finasteride	Finasteride	40	12
Fluticasone Propionate	Fluticasone Propionate	40	15
Xarelto	Rivaroxaban	40	12
Alprazolam	Alprazolam	39	16
Celecoxib	Celecoxib	38	12
Triamcinolone Acetonide	Triamcinolone Acetonide	38	20
Tizanidine Hcl	Tizanidine Hcl	37	15
Pravastatin Sodium	Pravastatin Sodium	36	11
Meloxicam	Meloxicam	35	13
Metoprolol Tartrate	Metoprolol Tartrate	35	13
Doxycycline Hyclate	Doxycycline Hyclate	34	24
Mirtazapine	Mirtazapine	34	13
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Jardiance	Empagliflozin	32	suppressed
Atenolol	Atenolol	31	suppressed
Estradiol	Estradiol	31	14
Spironolactone	Spironolactone	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Azithromycin	Azithromycin	27	25
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Topiramate	Topiramate	24	suppressed
Glipizide	Glipizide	23	suppressed
Diphenhydramine Hcl	Diphenhydramine Hcl	22	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	13
Valacyclovir	Valacyclovir Hcl	22	14
Acyclovir	Acyclovir	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Clonazepam	Clonazepam	21	suppressed
Methylprednisolone	Methylprednisolone	21	18
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Valsartan	Valsartan	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Liothyronine Sodium	Liothyronine Sodium	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Metformin Hcl Er	Metformin Hcl	16	suppressed
Ondansetron Odt	Ondansetron	16	13
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Warfarin Sodium	Warfarin Sodium	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Calcipotriene	Calcipotriene	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Fluconazole	Fluconazole	14	11
Myrbetriq	Mirabegron	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Clotrimazole	Clotrimazole	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Primidone	Primidone	13	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Toprol Xl	Metoprolol Succinate	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Baclofen	Baclofen	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Fetzima	Levomilnacipran Hcl	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Ramipril	Ramipril	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error